,T-bet+ CXCR3+ B B-T

Ivan Jelcic1, Reza Naghavian2, Imran Fanaswala3

  • 1Neuroimmunology and MS Research Section (NIMS), Neurology Clinic, University of Zurich, University Hospital Zurich, 8091 Zurich, Switzerland; Roche Pharma Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Cell reports. Medicine
|March 19, 2025
PubMed
概括

研究人员发现T-bet+CXCR3+B细胞通过放大T细胞反应来驱动多发性硬化症 (MS) 的炎症. 这些细胞在大脑和外周系统中都至关重要,影响着MS的进展.